Announcement on the Release of the 'Compliance Guidelines for Pharmaceutical Enterprises on Preventing Commercial Bribery Risks'

This document announces the official release and implementation of the 'Compliance Guidelines for Pharmaceutical Enterprises on Preventing Commercial Bribery Risks', which was adopted by the State Administration for Market Regulation.